Abstract
Pharmacokinetics has been recognized as one of the elements determining the probability of success in pharmaceutical research. As a result, compounds are routinely evaluated in drug discovery for their absorption, distribution, metabolism and elimination properties. The primary objective of these studies is to eliminate “flawed” molecules or a structural class based on preset selection criteria, while building a knowledge base for compilation of structure-activity relationships to guide chemistry synthesis efforts. This article is intended to provide a brief overview combined with critical evaluation on several strategies employed during lead optimization processes, and the analyses are supported by case studies. Future directions are discussed in the context of overcoming deficiencies in the current practice by developing tools enabling better prediction of clinical outcomes.
Keywords: Drug discovery, drug metabolism, pharmacokinetics, structure-activity relationship
Current Pharmaceutical Design
Title: Drug Metabolism and Pharmacokinetics in Support of Drug Design
Volume: 15 Issue: 19
Author(s): Wei Tang and Anthony Y.H. Lu
Affiliation:
Keywords: Drug discovery, drug metabolism, pharmacokinetics, structure-activity relationship
Abstract: Pharmacokinetics has been recognized as one of the elements determining the probability of success in pharmaceutical research. As a result, compounds are routinely evaluated in drug discovery for their absorption, distribution, metabolism and elimination properties. The primary objective of these studies is to eliminate “flawed” molecules or a structural class based on preset selection criteria, while building a knowledge base for compilation of structure-activity relationships to guide chemistry synthesis efforts. This article is intended to provide a brief overview combined with critical evaluation on several strategies employed during lead optimization processes, and the analyses are supported by case studies. Future directions are discussed in the context of overcoming deficiencies in the current practice by developing tools enabling better prediction of clinical outcomes.
Export Options
About this article
Cite this article as:
Tang Wei and Lu Y.H. Anthony, Drug Metabolism and Pharmacokinetics in Support of Drug Design, Current Pharmaceutical Design 2009; 15 (19) . https://dx.doi.org/10.2174/138161209788682451
DOI https://dx.doi.org/10.2174/138161209788682451 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
DNA Methyltransferase-1 Inhibitors as Epigenetic Therapy for Cancer
Current Cancer Drug Targets Non Polymeric Nanoparticles for Photodynamic Therapy Applications: Recent Developments
Current Medicinal Chemistry COX Selectivity and Animal Models for Colon Cancer
Current Pharmaceutical Design Bladder Cancer: Molecular Determinants of Personalized Therapy
Current Drug Targets P2X Receptors, Sensory Neurons and Pain
Current Medicinal Chemistry The Design and Synthesis of Novel Phenothiazine Derivatives as Potential Cytotoxic Agents
Letters in Drug Design & Discovery 2-Deoxy-D-Ribose, a Downstream Mediator of Thymidine Phosphorylase, Regulates Tumor Angiogenesis and Progression
Anti-Cancer Agents in Medicinal Chemistry Human Apurinic/Apyrimidinic Endonuclease (APE1): An Emerging Anti-Cancer Biomarker
Recent Patents on Biomarkers Silencing Human Cancer: Identification and Uses of MicroRNAs
Recent Patents on Anti-Cancer Drug Discovery Novel Methods for the Non-Invasive Administration of DNA Therapeutics and Vaccines
Current Drug Delivery Biological Properties of Citrus Flavonoids Pertaining to Cancer and Inflammation
Current Medicinal Chemistry Vitamin D Receptor Agonists, Cancer and the Immune System: An Intricate Relationship
Current Topics in Medicinal Chemistry Gene and Stem Cell Therapy in the Treatment of Erectile Dysfunction and Pulmonary Hypertension; Potential Treatments for the Common Problem of Endothelial Dysfunction
Current Gene Therapy One Special Question to Start with: Can HIF/NFkB be a Target in Inflammation?
Endocrine, Metabolic & Immune Disorders - Drug Targets Anti-Angiogenesis in the Treatment of Genito-Urinary Cancers: Last Updates
Current Angiogenesis (Discontinued) Potassium Channels in Peripheral Pain Pathways: Expression, Function and Therapeutic Potential
Current Neuropharmacology Agaricus blazei Water Extracts as Alternative Medicines
Current Pharmaceutical Analysis The Novel Functions of cGMP-Specific Phosphodiesterase 5 and its Inhibitors in Carcinoma Cells and Pulmonary/Cardiovascular Vessels
Current Topics in Medicinal Chemistry The Use of Transient Expression Systems for the Rapid Production of Virus-like Particles in Plants
Current Pharmaceutical Design Comparison of the Structure and Biological Activities of Wild-type and Mutant Liver-targeting Peptide Modified Recombinant Human Endostatin (rES-CSP) in Human Hepatocellular Carcinoma HepG2 Cells
Protein & Peptide Letters